27 September 2017 EMA/68528/2014 CORRECTION 4* Patient Health Protection

List of flupirtine-containing medicinal products in the European Union Name of the product

Marketing Authorisation Holder

Country where product is authorised

Katadolon

Teva Pharma B.V.

Estonia

Flupirtinmaleat AbZ 100 mg Kapseln

AbZ-Pharma GmbH

Germany

Flupirtinmaleat AL 100 mg Hartkapseln

Aliud Pharma GmbH

Germany

Awegal inject

AWD.pharma GmbH & Co. KG

Germany

Katadolon inject

AWD.pharma GmbH & Co. KG

Germany

Katadolon Kinderzäpfchen

AWD.pharma GmbH & Co. KG

Germany

Katadolon Zäpfchen

AWD.pharma GmbH & Co. KG

Germany

Trancopal Dolo

AWD.pharma GmbH & Co. KG

Germany

Trancopal Dolo Suppositorien

AWD.pharma GmbH & Co. KG

Germany

Katadolon S long

AWD.pharma GmbH & Co. KG

Germany

Katadolon

AWD.pharma GmbH & Co. KG

Germany

Trancolong

AWD.pharma GmbH & Co. KG

Germany

Katadolon retard

AWD.pharma GmbH & Co. KG

Germany

Flupirtinmaleat Winthrop 400 mg Retardtabletten

AWD.pharma GmbH & Co. KG

Germany

Flupirtinmaleat-CT 100 mg Hartkapsel

CT Arzneimittel GmmbH

Germany

Flupin 100 mg Hartkapseln

CT Arzneimittel GmmbH

Germany

Dolokadin einmal täglich

Dr. Kade Pharmazeutische

Germany

Flupigamma 100 mg Hartkapseln

Hormosan Pharma GmbH

Germany

Flupirtinmaleat-Hormosan 100 mg Hartkapseln

Hormosan Pharma GmbH

Germany

Flupigil 100 mg Hartkapseln

MEDA Pharma GmbH & Co. KG

Germany

Flupigil 100 mg Hartkapseln

MEDA Pharma GmbH & Co. KG

Germany

Flupirtinmaleat Midas 100 mg Hartkapseln

Midas Pharma GmbH

Germany

Flupirtinmaleat-ratiopharm 100 mg Hartkapsel

ratiopharm GmbH

Germany

Miflumal 100 mg Hartkapseln

ratiopharm GmbH

Germany

Flupirtinmaleat Vitapharma 100 mg Hartkapseln

Vitapharma Generics GmbH

Germany

Flupivil 100 mg Hartkapseln

Vitapharma Generics GmbH

Germany

Flupirtinmaleat Viatris 100 mg Hartkapseln

Vitapharma Generics GmbH

Germany

Flupirtinmaleat Winthrop 100 mg Hartkapseln

Winthrop Arzneimittel GmbH

Germany

Efiret **

MEDA PHARMA S.p.A.

Italy

Katadolon 100 mg hard capsules

Teva Pharma B.V.

Latvia

Katadolon

Teva Pharma B.V.

Lithuania

Katadolon

Teva Pharmaceuticals Polska Sp. z o.o.

Poland

Metanor

Meda Pharma - Produtos Farmacêuticos, S.A.

Portugal

Katadolon

TEVA Pharmaceuticals

Slovak Republic

* This annex was previously amended on 28 June 2017. ** The marketing authorisation of Efiret has been withdrawn, therefore it has been removed from this list.

Page 1

Flupirtine-containing medicinal products - European Medicines Agency

Name of the product. Marketing Authorisation Holder. Country where product is authorised. Katadolon. Teva Pharma B.V.. Estonia. Flupirtinmaleat AbZ 100 mg Kapseln. AbZ-Pharma GmbH. Germany. Flupirtinmaleat AL 100 mg Hartkapseln. Aliud Pharma GmbH. Germany. Awegal inject. AWD.pharma GmbH & Co. KG.

34KB Sizes 0 Downloads 239 Views

Recommend Documents

Desloraradine-containing medicinal products - European Medicines ...
Jun 22, 2017 - authorised originator product (Aerius) and considered data included in the ... Non-clinical data reveal no special hazard for humans based on ...

List of nationally authorised medicinal products - European Medicines ...
Jan 11, 2018 - LARGACTIL not available. PL 04425/0582. AVENTIS PHARMA LTD. UK. LARGACTIL 100 mg, comprimé pelliculé sécable not available. 305 712-4. SANOFI-AVENTIS FRANCE. FR. LARGACTIL 25 mg, comprimé pelliculé sécable not available. 305 711-

List of nationally authorised medicinal products - European Medicines ...
Jul 19, 2017 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in authorisation country) .... not available. 19158.

List of nationally authorised medicinal products - European Medicines ...
Sep 29, 2016 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name ... EKISTOL 50 mg comprimidos not available.

List of nationally authorised medicinal products - European Medicines ...
Jan 11, 2018 - List of nationally authorised medicinal products. EMA/24585/2018. Page 2/8. Product Name (in authorisation country). MRP/DCP Authorisation number. National Authorisation. Number. MAH of product in the member state. Member State where p

List of nationally authorised medicinal products - European Medicines ...
Jun 21, 2017 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in ... Sinemet retard-Tabletten not available.

List of nationally authorised medicinal products - European Medicines ...
Sep 1, 2017 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in authorisation ... not available. 68/0516/97-S.

List of nationally authorised medicinal products - European Medicines ...
Jul 6, 2017 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in authorisation country) ... not available. 68.620.

Regulatory Q&A on herbal medicinal products - European Medicines ...
Sep 20, 2016 - (R6) What kinds of safety data are required for applications ..... has to be demonstrated by using appropriate analytical data, for example.

List of nationally authorised medicinal products - European Medicines ...
Sep 29, 2016 - List of nationally authorised medicinal products cilostazol. EMA/648833/2016. Page 2/3. Product Name. (in authorisation country). MRP/DCP ...

List of nationally authorised medicinal products - European Medicines ...
Mar 9, 2017 - product is authorised. AFFERA 50 microgrammes/5 microgrammes par dose, suspension pour inhalation en flacon pressurisé. UK/H/4378/001.

List of nationally authorised medicinal products - European Medicines ...
26 Oct 2017 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom. An agency of the European Union. Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525. Send a question via our website www.ema.europa.eu/contact. © Europ

Notice - European Medicines Agency
Apr 28, 2017 - 2. The United Kingdom will then become a 'third country'. 3. Preparing for the withdrawal is therefore not just a matter for EU and national authorities, but also for private parties. In view of the considerable uncertainties, in parti

Report - European Medicines Agency
May 30, 2017 - Pharmaceutical companies are invited to present their pre-clinical data pertaining to ... patients per year, as many questions about the best use of ALK ... of knowledge and evidence to support the planning and regulatory.

Human Medicines Highlights Newsletter - European Medicines Agency
Mar 8, 2018 - Treatment of uterine fibroids. Haematology. New medicines authorised. • Adynovi (rurioctocog alfa pegol). Treatment and prevention of bleeding in patients with haemophilia A. New information on authorised medicines. • Feraccru (ferr

Veterinary medicines highlights 2016 - European Medicines Agency
Jan 26, 2017 - is an antiparasitic medicine that treats the Varroa mite infestation in honey-bee colonies, which is considered to be the most significant parasitic ...

Human Medicines Highlights Newsletter - European Medicines Agency
Treatment of cystine crystal deposits in the eye. New information on authorised medicines. Lucentis (ranibizumab) - change in indication. Treatment of visual ...

Human Medicines Highlights Newsletter - European Medicines Agency
The new EudraVigilance system and the electronic reporting of individual case ... the ISO/ICH E2B(R3) format: hands-on training course - October 2017 ... granted a conditional marketing authorisation on the basis of less complete clinical data ...

Agenda - European Medicines Agency - europa.eu
4 days ago - EMA/CAT/426129/2018. Page 2/17. Table of contents. 1. Introduction. 5. 1.1. Welcome and declarations of interest of members, alternates and ...

Finasteride - European Medicines Agency - europa.eu
Apr 25, 2018 - Page 2/8. Product Name (in authorisation country). MRP/DCP. Authorisation number. National Authorisation Number. MAH of product in the.

Agenda - European Medicines Agency - europa.eu
Sep 8, 2016 - 3-year report on Pharmacovigilance activities. Helen Lee, European Commission. •. Scanning the horizon for 2016 – 2018. Peter Arlett, EMA.

Human medicines highlights newsletter - European Medicines Agency
PCWP and HCPWP joint meeting - Sept 2016 - meeting documents. • Workshop on identifying opportunities for 'big data' in medicines development and ...

Human Medicines Highlights Newsletter - European Medicines Agency
Used for the management of hypovolaemia (low blood volume) caused by acute (sudden) blood loss .... EMA's Business Continuity Plan for Brexit published.

Agenda - European Medicines Agency veterinary medicines ...
On arriving for your meeting at 30 Churchill Place, please report to reception where you will be issued with an access pass. This pass will allow you to enter our industry lounge, which you are welcome to utilise during your visit. The industry loung